FREE Daily Stock Alerts From Stock-PR.com
MusclePharm Corporation (OTCQB:MSLP)
MSLP, one of the fastest growing nutritional supplement company with a proprietary formulation used in its portfolio of performance products, announced today that Ron Sekura, B.S., M.S., PhD., will join MSLP 's board of directors as its Director of Therapeutic Research.
Dr. Sekura will be assisting in the development of MSLP's therapeutic indication and application for patients with HIV experiencing catabolic cachexia.
Dr. Sekura commented, "I am very pleased to join the board of MusclePharm as it expands into the field of therapeutic nutritional supplementation for the application of HIV disease. Catabolic cashexia is a wasting condition that is physically devastating and extremely costly to treat. There has not been a great deal of successful response with the current therapeutic options but I believe Musclepharm is properly focusing on solving this condition."
Ron Sekura is currently President of VivoNex LLC and Biotechnology Assessment Services, Inc. Dr. Sekura is the former Chief of the Pharmaceutical and Regulatory Affairs Branch of the Division of AIDS at The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institute of Health (NIH), as well as a former Research Chemist at The National Institute of Child Health and Human Development (NICHD) at the NIH and the Center for Biologics Evaluation and Research (CBER). He received his Bachelor of Science and Master of Science in Biochemistry degrees at Pennsylvania State University and his PhD at Cornell University. Dr. Sekura is the author of over sixty scientific publications.
"We are thrilled to have Dr. Sekura join our Board of Directors. We believe Dr. Sekura's expertise at the FDA and NIAID, as well as his research and work at VivoNex regarding HIV drug adherence, will assist in our endeavor to provide our therapeutic nutritional supplementation, Re-con, to people with HIV experiencing involuntary weight loss, catabolic cachexia and nutrient deficiencies," stated MSLP President, Cory Gregory.
MSLP is presently preparing their application for Recon to be added to the Medicaid formulary, beginning in New York State for people diagnosed with HIV and AIDS as well as nation-wide Veterans Administration therapeutic formularies. In addition, MSLP is exploring the distribution of MusclePharm products, such as Recon, to people living with HIV in developing nations thru The Global Fund to Fight AIDS, Tuberculosis and Malaria, and The Presidents Emergency Plan for AIDS Relief (PEPFAR)."
MSLP's Recon Nutritional Supplement contains important amino acids, which assists in reaching the higher levels of nutrition required for people living with HIV. It is easily digestible, helps the absorption of amino acids and proteins. Recon contains essential minerals, digestive enzymes, Glutamine and other metabolic agents that maximize recovery, protein synthesis and endurance.
MSLP’s top management has extensive experience in the sports world and has harnessed this drive and focus into building a business to benefit its customers and help Fuel The Athlete Inside. Headquartered in Aurora, Colorado, MSLP is a fast-growing developer and manufacturer of safe, scientifically approved, nutritional supplements that are free of banned substances and tested by athletes. They are designed to help athletes, bodybuilders, weightlifters and fitness enthusiasts improve their performance. Each and every MSLP product is the end result of an advanced six-stage research and testing protocol involving the expertise of top nutrition scientists. In addition, the products have been field-tested by more than 100 elite professional athletes from the NFL, MMA, MLB and elsewhere. To date, MSLP has developed six products: ASSAULT, BATTLE FUEL, BULLET PROOF, COMBAT POWDER, RECON and SHRED MATRIX. Two additional products are due in stores in 2010. MSLP products offer up to twice as much of the active ingredients per serving as competing products and incorporate a proprietary mix of ingredients not available elsewhere. MSLP was founded in 2008 and is based in Aurora, Colorado.
To learn more about MSLP visit: http://www.musclepharm.com
The Dow Chemical Company (NYSE:DOW)
DOW announced this week plans to establish a Dow Design & Modify Supply Chain (D&MSC) center in Belfast, Northern Ireland. This Center will help to ensure that DOW’s supply chain is optimally designed to respond to emerging social and economic trends and customer needs around the globe. This move also reflects DOW’s commitment to leverage its Business Services expertise to drive more value to the market through DOW’s businesses and joint ventures as the Company seeks to become a high-growth earnings company.
DOW engages in the manufacture and sale of chemicals, plastic materials, agricultural, and other products and services worldwide. DOW’s Electronic and Specialty Materials segment offers materials for chemical mechanical planarization pads and slurries, chemical processing and intermediates, electronic displays, food and pharmaceutical processing and ingredients, PCB materials, semiconductor packaging, connectors and industrial finishing, and water purification.
IncrediMail Ltd. (NASDAQ:MAIL)
MAIL recently announced that its Board of Directors has approved an interim cash dividend for 2010 of $0.45 a share, totaling approximately $4.3 million.
The record date has been set as the close of the NASDAQ Global Market on September 20, 2010. The dividend will be payable to MAIL's shareholders of record on or about October 5, 2010. The dividend will be paid to MAIL's shareholders net of taxes withheld at the source, pursuant to the applicable provisions of Israeli law.
MetLife, Inc. (NYSE:MET)
Being a member of the working sandwich generation — those who are holding down a full-time job while raising children and simultaneously serving as a caregiver for older relatives — comes with a steep price tag. New findings released on October 19, 2010 from MetLife’s 8th Annual Employee Benefits Trends Study help quantify some of the pressures and costs and increasingly point to the workplace as a potential source for assistance. About one in five full-time employees is a caregiver of an older relative and nearly three-quarters of these employees also have children under the age of 18.
MET, through its subsidiaries, provides insurance, employee benefits, and financial services in the United States, Latin America, the Asia Pacific, Europe, the Middle East, and India. MET offers group life insurance products and services as employer-paid benefits, including variable life, universal life, and term life products, as well as employee paid supplemental life products; individual life insurance products and services comprising variable life, universal life, term life, and whole life products, as well as a range of mutual funds and other securities products.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings, Inc. (OTCPK:CRWE) has received twenty five thousand dollars in cash and seventy five thousand free trading shares from a third party (Bishop Equity Partners) for (30) days of advertising for Muscle Pharm Corp. (OTCQB:MSLP)
Sign Up For Free Stock Alerts At http://stock-pr.com/signup
________________________________________Be Sure To Visit stock-pr.ning.com
The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.